GlassScriptPhysician profile
Peter Frank Koltz
NPI 1316260797
$335,862.31
in general payments reported to CMS, 2019-2025
32 companies · $34K in 2025
The $34K reported for 2025 was more than what 98% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $2,458 · 2021: $20K · 2022: $256K · 2023: $513 · 2024: $150 · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $929 · Debt Forgiveness: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $33,600.00 |
| Food and Beverage | $928.82 |
| Debt Forgiveness | $159.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Innovation Associates, INC. | $254,099.22 | 2022 | |
| Bimini Technologies LLC | $33,600.00 | 2025 | |
| Surgalign Spine Technologies, INC. | $19,376.41 | 2019 | |
| Sanara Medtech INC. | $12,949.66 | 2020-2024 | Celleraterx |
| Rti Surgical, INC | $7,890.67 | 2021-2023 | |
| Sientra, INC. | $3,470.88 | 2019-2022 | |
| Vioptix INC | $1,660.46 | 2019-2021 | |
| Axogen | $602.10 | 2019-2025 | Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $483.85 | 2019-2024 | Tenoglide, Integra, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $368.93 | 2019-2022 | |
| Allergan, INC. | $209.98 | 2019-2022 | |
| Galderma Laboratories, L.P. | $199.02 | 2019-2025 | Dysport |
| Merit Medical Systems INC | $159.75 | 2025 | |
| Bard Peripheral Vascular, INC. | $144.94 | 2021 | |
| Tela Bio, INC. | $96.30 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $76.25 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Medtronic, INC. | $64.09 | 2022-2025 | Swiftset, Transorb |
| Vertex Pharmaceuticals Incorporated | $51.75 | 2025 | |
| Becton, Dickinson and Company | $47.90 | 2025 | Phasix Mesh |
| Baxter Healthcare | $47.06 | 2021-2024 | Perclot |
| Abbvie INC. | $40.21 | 2023-2025 | |
| Kci USA, INC. | $38.10 | 2020-2021 | |
| Depuy Synthes Sales INC. | $25.96 | 2025 | Healix Knotless Peek |
| Heron Therapeutics, INC. | $24.02 | 2023 | Zynrelef |
| Revance Therapeutics, INC. | $20.49 | 2025 | Daxxify |
| Merz North America, INC. | $18.88 | 2022 | |
| Coopersurgical, INC. | $18.41 | 2020 | |
| Kerecis Limited | $18.27 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.04 | 2019 | |
| Avita Medical Americas, LLC | $15.76 | 2024 | |
| Apyx Medical Corporation | $12.50 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Koltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.